Trinity Biotech Plc Sponsored ADR Class A Forecast, price target & analysts
Trinity Biotech Plc Sponsored ADR Class A Target price 2024 - Analyst rating & recommendation
Trinity Biotech Plc Sponsored ADR Class A Classifications & Recommendation:
Trinity Biotech Plc Sponsored ADR Class A Price Target
| Target Price | $15.00 |
| Price | $1.37 |
| Potential |
994.89%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Trinity Biotech Plc Sponsored ADR Class A price target 2025.
The average Trinity Biotech Plc Sponsored ADR Class A target price is $15.00.
This is
994.89%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend Trinity Biotech Plc Sponsored ADR Class A to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Trinity Biotech Plc Sponsored ADR Class A stock has an average upside potential 2025 of
994.89%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 56.83 | 62.20 |
| 24.00% | 9.45% | |
| Net Margin | -42.21% | -18.42% |
| 32.04% | 56.36% |
1 Analyst has issued a sales forecast Trinity Biotech Plc Sponsored ADR Class A 2024 . The average Trinity Biotech Plc Sponsored ADR Class A sales estimate is
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.14 | -1.50 |
| 48.36% | 52.23% | |
| P/E | negative | |
| EV/Sales | 1.67 |
The average Trinity Biotech Plc Sponsored ADR Class A <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Trinity Biotech Plc Sponsored ADR Class A stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Trinity Biotech Plc Sponsored ADR Class A...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
